Ishikawa T - Search Results

1

Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers.

Kamimura K, Suda T, Fukuhara Y, Okuda S, Watanabe Y, Yokoo T, Osaki A, Waguri N, Ishikawa T, Sato T, Aoyagi Y, Takamura M, Wakai T, Terai S. Kamimura K, et al. Among authors: ishikawa t. Sci Rep. 2021 Mar 18;11(1):6255. doi: 10.1038/s41598-021-85498-7. Sci Rep. 2021. PMID: 33737617 Free PMC article.

2

Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells.

Yamagiwa S, Matsuda Y, Ichida T, Honda Y, Takamura M, Sugahara S, Ishikawa T, Ohkoshi S, Sato Y, Aoyagi Y. Yamagiwa S, et al. Among authors: ishikawa t. Hepatol Res. 2008 Jul;38(7):664-72. doi: 10.1111/j.1872-034X.2008.00317.x. Epub 2008 Mar 4. Hepatol Res. 2008. PMID: 18328072

3

Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Tamura Y, Yamagiwa S, Aoki Y, Kurita S, Suda T, Ohkoshi S, Nomoto M, Aoyagi Y; Niigata Liver Disease Study Group. Tamura Y, et al. Dig Dis Sci. 2009 Nov;54(11):2530-7. doi: 10.1007/s10620-008-0642-y. Epub 2008 Dec 18. Dig Dis Sci. 2009. PMID: 19093203

4

Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil.

Tsuchiya A, Imai M, Kamimura H, Togashi T, Watanabe K, Seki K, Ishikawa T, Ohta H, Yoshida T, Kamimura T. Tsuchiya A, et al. Among authors: ishikawa t. World J Gastroenterol. 2009 Apr 14;15(14):1779-81. doi: 10.3748/wjg.15.1779. World J Gastroenterol. 2009. PMID: 19360925 Free PMC article.

5

Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C.

Aoki YH, Ohkoshi S, Yamagiwa S, Yano M, Takahashi H, Waguri N, Igarashi K, Sugitani S, Takahashi T, Ishikawa T, Kamimura T, Wakabayashi H, Watanabe T, Matsuda Y, Nomoto M, Aoyagi Y. Aoki YH, et al. Among authors: ishikawa t. Hepatol Res. 2011 Feb;41(2):118-25. doi: 10.1111/j.1872-034X.2010.00749.x. Hepatol Res. 2011. PMID: 21269381

6

Formula to predict platelet count after partial splenic arterial embolization in patients with hypersplenism.

Osaki A, Suda T, Waguri N, Ishikawa T, Yokoo T, Kamimura K, Tamura Y, Takamura M, Igarashi M, Kawai H, Yamagiwa S, Aoyagi Y. Osaki A, et al. Among authors: ishikawa t. J Vasc Interv Radiol. 2012 Jul;23(7):900-7. doi: 10.1016/j.jvir.2012.03.008. Epub 2012 May 24. J Vasc Interv Radiol. 2012. PMID: 22633618 Clinical Trial.

7

Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure.

Yamagiwa S, Tamura Y, Takamura M, Genda T, Ichida T, Ishikawa T, Kamimura T, Takahashi T, Suda T, Matsuda Y, Nomoto M, Aoyagi Y. Yamagiwa S, et al. Among authors: ishikawa t. Hepatol Res. 2014 Dec;44(14):E368-75. doi: 10.1111/hepr.12318. Epub 2014 Mar 25. Hepatol Res. 2014. PMID: 24612069

8

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C.

Yamagiwa S, Ishikawa T, Waguri N, Sugitani S, Wakabayashi H, Ohkoshi S, Tsukishiro T, Takahashi T, Watanabe T, Terai S. Yamagiwa S, et al. Among authors: ishikawa t. World J Hepatol. 2017 Feb 18;9(5):252-262. doi: 10.4254/wjh.v9.i5.252. World J Hepatol. 2017. PMID: 28261382 Free PMC article.

9

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.

Yamagiwa S, Ishikawa T, Waguri N, Sugitani S, Kamimura K, Tsuchiya A, Takamura M, Kawai H, Terai S. Yamagiwa S, et al. Among authors: ishikawa t. Int J Med Sci. 2017 Apr 8;14(5):403-411. doi: 10.7150/ijms.18784. eCollection 2017. Int J Med Sci. 2017. PMID: 28539815 Free PMC article.

10

Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial.

Suzuki K, Endo R, Takikawa Y, Moriyasu F, Aoyagi Y, Moriwaki H, Terai S, Sakaida I, Sakai Y, Nishiguchi S, Ishikawa T, Takagi H, Naganuma A, Genda T, Ichida T, Takaguchi K, Miyazawa K, Okita K. Suzuki K, et al. Among authors: ishikawa t. Hepatol Res. 2018 May;48(6):411-423. doi: 10.1111/hepr.13045. Epub 2018 Jan 19. Hepatol Res. 2018. PMID: 29235218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,817 results

Search Page

Filters